Stock Events

Stock Events

Emergent Health 

$0
7
+$0+0% Tuesday 14:30

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
100,000
Avg. Volume
114,862
Mkt Cap
42,695.1
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q4 2010
Q1 2011
Q2 2011
Q3 2011
Q2 2013
Q3 2013
Q2 2014
-0
0
0
0.01
Expected EPS
0
Actual EPS
-0.0019

Financials

-99.57%Profit Margin
Unprofitable
2014
2019
2020
2021
2022
2023
3.27MRevenue
-3.26MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EMGE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with Emergent Health in the development and marketing of medications and vaccines for a wide range of medical conditions.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceutical sector, offering products that directly compete with Emergent Health's offerings in healthcare solutions.
Merck
MRK
Mkt Cap214.76B
Merck is a leading pharmaceutical company that develops drugs and vaccines, competing with Emergent Health in various therapeutic areas.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that competes with Emergent Health in the development of treatments for infectious diseases, among other areas.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a research-based biopharmaceutical company that competes with Emergent Health in developing advanced therapies for complex health conditions.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company focused on human therapeutics, competing with Emergent Health in the biotech and healthcare sector.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Emergent Health in the discovery, development, and delivery of medicines.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that competes with Emergent Health in providing healthcare solutions across a broad range of therapies.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global biopharmaceutical company focused on human health, competing with Emergent Health in the development of pharmaceuticals and vaccines.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company, competing with Emergent Health in the development and commercialization of prescription medicines.

About

Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.
Show more...
CEO
Mr. James W. Zimbler
Employees
6
Country
US
ISIN
US29100Q3083

Listings

OTC Link
US
EMGE

0 Comments

Share your thoughts

FAQ

What is Emergent Health stock price today?▼
The current price of EMGE is $0 USD — it has increased by +0% in the past 24 hours. Watch Emergent Health stock price performance more closely on the chart.
What is Emergent Health stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Emergent Health stocks are traded under the ticker EMGE.
Is Emergent Health stock price growing?▼
EMGE stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Emergent Health has showed a -85.71% decrease.
What is Emergent Health market cap?▼
Today Emergent Health has the market capitalization of 42,695.1
What were Emergent Health earnings last quarter?▼
EMGE earnings for the last quarter are -0 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Emergent Health revenue for the last year?▼
Emergent Health revenue for the last year amounts to 3.27M USD.
What is Emergent Health net income for the last year?▼
EMGE net income for the last year is -3.26M USD.
How many employees does Emergent Health have?▼
As of April 03, 2026, the company has 6 employees.
In which sector is Emergent Health located?▼
Emergent Health operates in the Health Care sector.
When did Emergent Health complete a stock split?▼
The last stock split for Emergent Health was on July 24, 2008 with a ratio of 1:50.
Where is Emergent Health headquartered?▼
Emergent Health is headquartered in King of Prussia, US.